Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(10)

BIOLOGICAL(7)

GENETIC(1)

MIXED(1)

Ad-RTS-hIL-12

6 trials

phase_1phase_1_2phase_2

alaunos-therapeutics

veledimex

5 trials

phase_1phase_1_2phase_2

Ad-RTS-hIL-12 and Veledimex

1 trial

phase_2

alaunos-therapeutics

Oral Veledimex - Arm 1 (Pediatric Brain Tumor)

Oral Veledimex - Arm 2 (DIPG)

+2 more interventions

10 unique interventions4 categories

Analytics

Trial Phases

Phase 16

Phase 25

Trial Status

Completed4

Terminated4

Role Distribution

Other Roles8

Activity Timeline

Clinical Trials (8)

NCT04006119Phase 2Terminated

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Glioblastoma

StudydirectorStart date: 2019-08-01

NCT03679754Phase 1Completed

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

Glioblastoma

StudydirectorStart date: 2018-09-05

NCT03636477Phase 1Completed

A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102

Glioblastoma

StudydirectorStart date: 2018-06-18

NCT03330197Phase 1/2Terminated

A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

Diffuse Intrinsic Pontine GliomaPediatric Brain Tumor

StudydirectorStart date: 2017-09-26

NCT02423902Phase 1/2Terminated

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer

Metastatic Breast Cancer

StudydirectorStart date: 2015-07-18

NCT01703754Phase 2Terminated

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Breast Cancer Nos Metastatic Recurrent

StudydirectorStart date: 2013-04-04

NCT01397708Phase 1/2Completed

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Melanoma

Studydirector

NCT02026271Phase 1Completed

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Anaplastic OligoastrocytomaGlioblastoma Multiforme

Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Glioblastoma3 Anaplastic Oligoastrocytoma1 Breast Cancer Nos Metastatic Recurrent1 Diffuse Intrinsic Pontine Glioma1 Glioblastoma Multiforme1 Melanoma1 Metastatic Breast Cancer1 Pediatric Brain Tumor1

Affiliations

Alaunos Therapeutics

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maryam Fouladi, MD

Nationwide Children's Hospital

10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaGlioblastomaGlioblastoma Multiforme

Similarity Score11%

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma MultiformeMetastatic Breast Cancer

Similarity Score11%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

MelanomaGlioblastoma

Similarity Score8%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

16 trials

Shared therapeutic areas:

MelanomaGlioblastoma

Similarity Score8%

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

17 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme

Similarity Score8%

Jennifer Temel, MD

Massachusetts General Hospital

12 trials

Shared therapeutic areas:

MelanomaMetastatic Breast Cancer

Similarity Score8%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

13 trials

Shared therapeutic areas:

Metastatic Breast Cancer

Similarity Score4%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

11 trials

Shared therapeutic areas:

Metastatic Breast Cancer

Similarity Score4%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

12 trials

Shared therapeutic areas:

Glioblastoma Multiforme

Similarity Score4%

Jeffrey Raizer, MD

Northwestern University

8 trials

Shared therapeutic areas:

Glioblastoma Multiforme

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT04006119Phase 2StudyDirector

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Glioblastoma

Terminated

NCT03679754Phase 1StudyDirector

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

Glioblastoma

Completed

NCT03636477Phase 1StudyDirector

A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102

Glioblastoma

Completed

NCT03330197Phase 1/2StudyDirector

A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

Diffuse Intrinsic Pontine GliomaPediatric Brain Tumor

Terminated

NCT02423902Phase 1/2StudyDirector

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer

Metastatic Breast Cancer

Terminated

NCT01703754Phase 2StudyDirector

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Breast Cancer Nos Metastatic Recurrent

Terminated

NCT01397708Phase 1/2StudyDirector

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Melanoma

Completed

NCT02026271Phase 1StudyDirector

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Anaplastic OligoastrocytomaGlioblastoma Multiforme

Completed

All 8 trials loaded